You save $69.98
CRISC Premium Bundle
- Premium File 1105 Questions & Answers
- Last Update: Nov 10, 2026
- Training Course 64 Lectures
- Study Guide 498 Pages
You save $69.98
An organization is preventing a recurrence of this risk pattern: An audit finding for database encryption is marked resolved after a ticket says 'configuration updated.' Which ongoing safeguard would best prevent recurrence of this specific failure mode?
Tie ticket closure to independent control acceptance tests. This safeguard addresses the recurring failure rather than only the current event. The expected verification is: Technical evidence shows encrypted storage, correct key handling and independent closure approval.
Require control type and objective mapping during control design reviews. That safeguard prevents failures associated with preventive versus detective mix and does not directly prevent this remediation retest recurrence. The applicable continuing control is: Tie ticket closure to independent control acceptance tests.
Monitor ingestion delay as a key control health indicator. That safeguard prevents failures associated with security control dependency and does not directly prevent this remediation retest recurrence. The applicable continuing control is: Tie ticket closure to independent control acceptance tests.
Automate overdue-risk escalation with evidence-based closure criteria. That safeguard prevents failures associated with risk action overdue and does not directly prevent this remediation retest recurrence. The applicable continuing control is: Tie ticket closure to independent control acceptance tests.
A risk leader is reviewing this situation: A risk response plan says 'improve disaster recovery this year' without measurable milestones or ownership. Which next step would most directly treat or govern the risk in this situation?
Define accountable milestones for recovery dependency fixes, timed drills and approved target outcomes. Action plans translate treatment decisions into monitorable implementation commitments. Evidence that the action has worked would be: Plan records identify owner, date, funded actions, acceptance evidence and risk status changes.
Define a forward-looking KRI linked to unauthorized access attempts and privileged exposure with approved warning thresholds. That change is aimed at kri threshold selection, whereas this decision must address treatment milestone quality. The relevant first comparison is: Compare the stated plan with observed recovery failures and governance deadlines.
Select targeted mitigation by fixing token exposure and restricting endpoint privileges with a funded owner-approved plan. That change is aimed at risk mitigation selection, whereas this decision must address treatment milestone quality. The relevant first comparison is: Compare the stated plan with observed recovery failures and governance deadlines.
Design and implement separation of duties for initiation and final release using distinct approved roles. That change is aimed at business process authorization, whereas this decision must address treatment milestone quality. The relevant first comparison is: Compare the stated plan with observed recovery failures and governance deadlines.
A risk owner seeks evidence following review of this situation: A risk response plan says 'improve disaster recovery this year' without measurable milestones or ownership. Which evidence would best demonstrate that the intended risk response is functioning?
Plan records identify owner, date, funded actions, acceptance evidence and risk status changes. This evidence addresses the stated risk rather than showing only that a control was configured. Action plans translate treatment decisions into monitorable implementation commitments.
Updated risk records reflect validated segmentation boundaries and risk-owner decisions. That observation may help validate dynamic residual risk review, but it does not establish the acceptance condition for treatment milestone quality. Here, the decisive evidence is: Plan records identify owner, date, funded actions, acceptance evidence and risk status changes.
The roadmap identifies vulnerable crypto dependencies, retained-data horizons and funded review milestones. That observation may help validate post-quantum transition risk, but it does not establish the acceptance condition for treatment milestone quality. Here, the decisive evidence is: Plan records identify owner, date, funded actions, acceptance evidence and risk status changes.
The source dataset links each claimed review to dated approval and access population evidence. That observation may help validate missing control evidence, but it does not establish the acceptance condition for treatment milestone quality. Here, the decisive evidence is: Plan records identify owner, date, funded actions, acceptance evidence and risk status changes.
A governance team is discussing the underlying cause in this situation: A risk response plan says 'improve disaster recovery this year' without measurable milestones or ownership. Which risk-management principle most directly explains the correct approach?
Action plans translate treatment decisions into monitorable implementation commitments. The immediate management action is: Define accountable milestones for recovery dependency fixes, timed drills and approved target outcomes.
A monitoring control must deliver actionable signals and responses, not merely emit events. That principle is relevant to monitoring response gaps, not the mechanism implicated by the stated treatment milestone quality situation. In this case: Action plans translate treatment decisions into monitorable implementation commitments.
Data transformation errors can change governance decisions even when the original system is accurate. That principle is relevant to unvalidated data transformations, not the mechanism implicated by the stated treatment milestone quality situation. In this case: Action plans translate treatment decisions into monitorable implementation commitments.
Control documentation demonstrates design; transaction testing checks actual operation over time. That principle is relevant to design versus operating effectiveness, not the mechanism implicated by the stated treatment milestone quality situation. In this case: Action plans translate treatment decisions into monitorable implementation commitments.
A risk committee is deciding whether an unresolved exposure can be tolerated: A risk response plan says 'improve disaster recovery this year' without measurable milestones or ownership. What is the most relevant avoidable consequence if the weakness remains unresolved?
Vague milestones allow unresolved recovery gaps to persist without escalation. This consequence follows from the specific missing governance or technical safeguard. Action plans translate treatment decisions into monitorable implementation commitments. The appropriate response is: Define accountable milestones for recovery dependency fixes, timed drills and approved target outcomes.
Ignored alerts permit exposures to persist while dashboards appear to function. That potential consequence concerns monitoring response gaps, rather than the direct risk described by treatment milestone quality. Here the material exposure is: Vague milestones allow unresolved recovery gaps to persist without escalation.
Incorrect aging may hide expired high-risk vulnerabilities or trigger false escalations. That potential consequence concerns unvalidated data transformations, rather than the direct risk described by treatment milestone quality. Here the material exposure is: Vague milestones allow unresolved recovery gaps to persist without escalation.
Fast ticket closure can coexist with weak MFA control coverage. That potential consequence concerns kpi versus kci confusion, rather than the direct risk described by treatment milestone quality. Here the material exposure is: Vague milestones allow unresolved recovery gaps to persist without escalation.
Before making a treatment decision, an analyst is investigating this situation: A risk response plan says 'improve disaster recovery this year' without measurable milestones or ownership. Which targeted first investigation would best clarify the risk before action is approved?
Compare the stated plan with observed recovery failures and governance deadlines. This isolates the relevant cause before changing unrelated controls. An appropriate follow-up is: Define accountable milestones for recovery dependency fixes, timed drills and approved target outcomes.
Reconcile the full restore-test population with the selected evidence and failures. That investigation concerns sampling independence and would not isolate the first implicated dependency here. The targeted check is: Compare the stated plan with observed recovery failures and governance deadlines.
Compare policy exclusions with business interruption dependencies and recovery objectives. That investigation concerns risk transfer limitations and would not isolate the first implicated dependency here. The targeted check is: Compare the stated plan with observed recovery failures and governance deadlines.
Compare past findings, tickets, restore failures and independent test evidence. That investigation concerns repeat finding escalation and would not isolate the first implicated dependency here. The targeted check is: Compare the stated plan with observed recovery failures and governance deadlines.
An organization is preventing a recurrence of this risk pattern: A risk response plan says 'improve disaster recovery this year' without measurable milestones or ownership. Which ongoing safeguard would best prevent recurrence of this specific failure mode?
Report overdue milestones and residual exposure at risk committee meetings. This safeguard addresses the recurring failure rather than only the current event. The expected verification is: Plan records identify owner, date, funded actions, acceptance evidence and risk status changes.
Test alert workflow routing and overdue escalation periodically. That safeguard prevents failures associated with monitoring response gaps and does not directly prevent this treatment milestone quality recurrence. The applicable continuing control is: Report overdue milestones and residual exposure at risk committee meetings.
Track replacement milestones and periodically retest the compensating boundary. That safeguard prevents failures associated with compensating control design and does not directly prevent this treatment milestone quality recurrence. The applicable continuing control is: Report overdue milestones and residual exposure at risk committee meetings.
Review board report usefulness and decision traceability each quarter. That safeguard prevents failures associated with board reporting relevance and does not directly prevent this treatment milestone quality recurrence. The applicable continuing control is: Report overdue milestones and residual exposure at risk committee meetings.
A risk leader is reviewing this situation: A global bank commits to deploy privileged access management across 200 servers without funding or staff allocation. Which next step would most directly treat or govern the risk in this situation?
Replan treatment with verified resources, phased scope and risk-based priorities approved by sponsors. Treatment feasibility depends on resourced ownership, not merely a nominal deadline. Evidence that the action has worked would be: The plan contains funded phases and tests proving sensitive servers moved under PAM controls.
Harden identity recovery with verified caller proofing, approval, and monitored step-up controls. That change is aimed at strong mfa recovery, whereas this decision must address resourcing and treatment. The relevant first comparison is: Compare approved budgets and engineer capacity with the server inventory and rollout schedule.
Present risk exposure, trend versus tolerance, treatment decisions and impacts at a board-appropriate level. That change is aimed at board reporting relevance, whereas this decision must address resourcing and treatment. The relevant first comparison is: Compare approved budgets and engineer capacity with the server inventory and rollout schedule.
Record long-horizon cryptographic transition risk and evaluate phased crypto-inventory and migration planning. That change is aimed at post-quantum transition risk, whereas this decision must address resourcing and treatment. The relevant first comparison is: Compare approved budgets and engineer capacity with the server inventory and rollout schedule.
A risk owner seeks evidence following review of this situation: A global bank commits to deploy privileged access management across 200 servers without funding or staff allocation. Which evidence would best demonstrate that the intended risk response is functioning?
The plan contains funded phases and tests proving sensitive servers moved under PAM controls. This evidence addresses the stated risk rather than showing only that a control was configured. Treatment feasibility depends on resourced ownership, not merely a nominal deadline.
The roadmap identifies vulnerable crypto dependencies, retained-data horizons and funded review milestones. That observation may help validate post-quantum transition risk, but it does not establish the acceptance condition for resourcing and treatment. Here, the decisive evidence is: The plan contains funded phases and tests proving sensitive servers moved under PAM controls.
KRI alerts provide warning before outages and are linked to capacity response actions. That observation may help validate early-warning risk indicator, but it does not establish the acceptance condition for resourcing and treatment. Here, the decisive evidence is: The plan contains funded phases and tests proving sensitive servers moved under PAM controls.
The control framework mapping lists relevant risks, selected controls, exclusions, and accountable owners. That observation may help validate framework tailoring, but it does not establish the acceptance condition for resourcing and treatment. Here, the decisive evidence is: The plan contains funded phases and tests proving sensitive servers moved under PAM controls.
A governance team is discussing the underlying cause in this situation: A global bank commits to deploy privileged access management across 200 servers without funding or staff allocation. Which risk-management principle most directly explains the correct approach?
Treatment feasibility depends on resourced ownership, not merely a nominal deadline. The immediate management action is: Replan treatment with verified resources, phased scope and risk-based priorities approved by sponsors.
A monitoring control must deliver actionable signals and responses, not merely emit events. That principle is relevant to monitoring response gaps, not the mechanism implicated by the stated resourcing and treatment situation. In this case: Treatment feasibility depends on resourced ownership, not merely a nominal deadline.
Risk ownership follows authority over business impact; control ownership covers operation of protections. That principle is relevant to critical business risk ownership, not the mechanism implicated by the stated resourcing and treatment situation. In this case: Treatment feasibility depends on resourced ownership, not merely a nominal deadline.
Mitigation reduces likelihood or impact by strengthening effective controls instead of merely documenting the loss. That principle is relevant to risk mitigation selection, not the mechanism implicated by the stated resourcing and treatment situation. In this case: Treatment feasibility depends on resourced ownership, not merely a nominal deadline.
A risk committee is deciding whether an unresolved exposure can be tolerated: A global bank commits to deploy privileged access management across 200 servers without funding or staff allocation. What is the most relevant avoidable consequence if the weakness remains unresolved?
An unfunded commitment creates false assurance and prolonged exposure on critical assets. This consequence follows from the specific missing governance or technical safeguard. Treatment feasibility depends on resourced ownership, not merely a nominal deadline. The appropriate response is: Replan treatment with verified resources, phased scope and risk-based priorities approved by sponsors.
Untested exit procedures can cause transaction gaps and prolonged settlement interruption. That potential consequence concerns third-party exit risk, rather than the direct risk described by resourcing and treatment. Here the material exposure is: An unfunded commitment creates false assurance and prolonged exposure on critical assets.
Local approval beyond authority can create invalid acceptance and unmanaged corporate exposure. That potential consequence concerns approval authority limit, rather than the direct risk described by resourcing and treatment. Here the material exposure is: An unfunded commitment creates false assurance and prolonged exposure on critical assets.
Excluding failures can give false assurance that backup recovery consistently works. That potential consequence concerns sampling independence, rather than the direct risk described by resourcing and treatment. Here the material exposure is: An unfunded commitment creates false assurance and prolonged exposure on critical assets.
or Guarantee your success by buying the full version which covers the full latest pool of questions. (1105 Questions, Last Updated on Nov 10, 2026)
Please check your mailbox for a message from support@examlabs.com and follow the directions.